<?xml version="1.0"?>
<notificationOfRemoval>

    <schemaVersion>X0203</schemaVersion>

    <exchange>
        <cik>0001143313</cik>
        <entityName>NYSE Amex</entityName>
    </exchange>

    <issuer>
        <cik>0001068874</cik>
        <entityName>IMPLANT SCIENCES CORP</entityName>
        <fileNumber>001-14949</fileNumber>
        <address>
            <street1>107 Audobon Road #5</street1>
            <street2></street2>
            <city>Wakefield</city>
            <stateOrCountryCode>MA</stateOrCountryCode>
            <stateOrCountry>MASSACHUSETTS</stateOrCountry>
            <zipCode>01880</zipCode>
        </address>
        <telephoneNumber>781-246-0700</telephoneNumber>
    </issuer>

    <descriptionClassSecurity>Common Stock, $0.10 Par Value;</descriptionClassSecurity>

    <ruleProvision>17 CFR 240.12d2-2(b)</ruleProvision>

    <signatureData>
        <signatureName>Janice O'Neill</signatureName>
        <signatureTitle>Senior Vice President - Corporate Compliance</signatureTitle>
        <signatureDate>2009-06-11</signatureDate>
    </signatureData>
</notificationOfRemoval>
